Price Controls

The latest Keynesian money-printing and spending schemes are blowing up. It is time to hear what the Austrians have to say.

Last year, Joe Biden and his administration claimed that inflation was "transitory." This year, Vladimir Putin gets the blame. Next year, Biden will blame American businesses. And the beat goes on.

The patent system in pharmaceuticals incentivizes firms to game the system for monopoly profits.

Last year, Joe Biden and his administration claimed that inflation was "transitory." This year, Vladimir Putin gets the blame. Next year, Biden will blame American businesses. And the beat goes on.

The patent system in pharmaceuticals incentivizes firms to game the system for monopoly profits.

While government officials and politicians denounce high drug prices, they have created monopoly privileges for drug firms, thus ensuring higher-than-competitive prices for pharmaceuticals.

While government officials and politicians denounce high drug prices, they have created monopoly privileges for drug firms, thus ensuring higher-than-competitive prices for pharmaceuticals.

People often react to sudden price changes by demanding that government "do something" to bring prices down. It is important to understand the mentality behind such beliefs.

Bob critiques a Guardian article from an economist favoring price controls, and explains his argument with Joe Weisenthal about the social benefit of saving actual cash.

Price controls, or antigouging laws, discourage innovation and sometimes can lead to supplies of goods and services being directed to other markets. In other words, price controls lead to shortages.